CorMedix Inc’s recent filing unveils that its EVP, Chief Commercial Officer Mistry Erin acquired Company’s shares for reported $14985.0 on Oct 31 ’24. In the deal valued at $9.99 per share,1,500 shares were bought. As a result of this transaction, Mistry Erin now holds 52,011 shares worth roughly $0.53 million.
Then, Hurlburt Elizabeth sold 140,027 shares, generating $1,565,670 in total proceeds. Upon selling the shares at $11.18, the EVP now owns 45,397 shares.
Before that, Hurlburt Elizabeth bought 140,027 shares. CorMedix Inc shares valued at $1,556,416 were divested by the Officer at a price of $11.12 per share.
D. Boral Capital initiated its CorMedix Inc [CRMD] rating to a Buy in a research note published on January 13, 2025; the price target was $15. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. RBC Capital Mkts began covering CRMD with “an Outperform” recommendation on August 10, 2023. Needham started covering the stock on February 17, 2021. It rated CRMD as “a Buy”.
Price Performance Review of CRMD
On Friday, CorMedix Inc [NASDAQ:CRMD] saw its stock fall -6.38% to $10.13. Over the last five days, the stock has lost -2.97%. CorMedix Inc shares have risen nearly 25.06% since the year began. Nevertheless, the stocks have risen 207.90% over the past one year. While a 52-week high of $13.85 was reached on 01/17/25, a 52-week low of $3.03 was recorded on 01/06/25. SMA at 50 days reached $10.11, while 200 days put it at $7.72.
Levels Of Support And Resistance For CRMD Stock
The 24-hour chart illustrates a support level at 9.83, which if violated will result in even more drops to 9.54. On the upside, there is a resistance level at 10.71. A further resistance level may holdings at 11.30. The Relative Strength Index (RSI) on the 14-day chart is 44.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.16%. Stochastics %K at 59.17% indicates the stock is a holding.
The most recent change occurred on September 29, 2020 when JMP Securities began covering the stock and recommended ‘”a Mkt outperform”‘ rating along with a $22 price target.
